AAAAAA

   
Results: 1-7 |
Results: 7
Pelvic malignant ectomesenchymoma: a case report
Authors: Paramelle, O Croue, A Dupre, F Rialland, X Saint-Andre, JP
Citation: O. Paramelle et al., Pelvic malignant ectomesenchymoma: a case report, ANN PATHOL, 21(4), 2001, pp. 344-347
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report
Authors: Vilmer, E Suciu, S Ferster, A Bertrand, Y Cave, H Thyss, A Benoit, Y Dastugue, N Fournier, M Souillet, G Manel, AM Robert, A Nelken, B Millot, F Lutz, P Rialland, X Mechinaud, F Boutard, P Behar, C Chantraine, JM Plouvier, E Laureys, G Brock, P Uyttebroeck, A Margueritte, G Plantaz, D Norton, L Francotte, N Gyselinck, J Waterkeyn, C Solbu, G Philippe, N Otten, J
Citation: E. Vilmer et al., Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report, LEUKEMIA, 14(12), 2000, pp. 2257-2266
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organizationfor Research and Treatment of Cancer 58881 Randomized Phase III Trial
Authors: Millot, F Suciu, S Philippe, N Benoit, Y Mazingue, F Uyttebroeck, A Lutz, P Mechinaud, F Robert, A Boutard, P Marguerite, G Ferster, A Plouvier, E Rialland, X Behard, C Plantaz, D Dresse, MF Philippet, P Norton, L Thyss, A Dastugue, N Waterkeyn, C Vilmer, E Otten, J
Citation: F. Millot et al., Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organizationfor Research and Treatment of Cancer 58881 Randomized Phase III Trial, J CL ONCOL, 19(7), 2000, pp. 1935-1942
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology
Authors: Minard, V Hartmann, O Peyroulet, MC Michon, J Coze, C Defachelle, AS Lejars, O Perel, Y Bergeron, C Boutard, P Leverger, G Stephan, JL Thyss, A Chastagner, P Couillault, G Devalck, C Lutz, P Mechinaud, F Millot, F Plantaz, D Rialland, X Rubie, H
Citation: V. Minard et al., Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology, BR J CANC, 83(8), 2000, pp. 973-979
Treatment outcome in infant acute lymphoblastic leukemia
Authors: Ferster, A Benoit, Y Francotte, N Dresse, MF Uyttebroeck, A Plouvier, E Thyss, A Lutz, P Marguerite, G Behar, C Mazingue, F Boutard, P Millot, F Rialland, X Mechinaud, F Norton, L Robert, A Otten, J Vilmer, E Philippe, N Waterkeyn, C Suciu, S
Citation: A. Ferster et al., Treatment outcome in infant acute lymphoblastic leukemia, BLOOD, 95(8), 2000, pp. 2729-2730
Use of intravenous ketamine-midazolam association for pain procedures in children with cancer. A prospective study
Authors: Pellier, I Monrigal, JP Le Moine, P Rod, B Rialland, X Granry, JC
Citation: I. Pellier et al., Use of intravenous ketamine-midazolam association for pain procedures in children with cancer. A prospective study, PAEDIATR AN, 9(1), 1999, pp. 61-68
Nephroblastoma clinical trial and study SIOP 93-01
Authors: de Kraker, J Ninane, J Sariban, E Chantraine, JM Clausen, N Yssing, M Tournade, MF Pautard, B Rialland, X",Plouvier,"Perel, Y",Berthouc,"Boutard, P",Plantaz,"Demaille, MC Nelken, B de Lumley, L Gentet, JC Mechinaud, F Thyss, A",Zucker,"Leverger, G Lutz, P Rubie, H Lejars, O Sternschulte, W Graf, N Donfrancesco, A Carli, M Schouten, N Bokkerink, JPM",Pereira,Madsen,"Stokland, T Moe, PJ Sanchez, J",Navajas,"Garcia-Miguel, P",Culic,Sawicz-Birkowska,Benedik-Dolnicar,"Makic, D
Citation: J. De Kraker et al., Nephroblastoma clinical trial and study SIOP 93-01, BIOM HLTH R, 24, 1998, pp. 13-16
Risultati: 1-7 |